Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 2023016 · TTRX

Turn Therapeutics Inc.

Filing with the SEC SEC-reporting company Westlake Village, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Net loss in 2025Net loss of $3.2M for the year (2024: −$1.8M).
  • Private capital raiseOn Aug 26, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$3.2M−$1.8M
Total assets$12.2M$2M
Total liabilities$7.5M$2.2M
Stockholders’ equity$4.7M−$177K
Cash and equivalents$4M$498K

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Turn Therapeutics Inc.
Formerly: Global Health Solutions, Inc
CIK
0002023016
Tickers
TTRX
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Westlake Village, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 9, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 9, 2026 · filing · edition of Nov 9, 2026
  • Private raise (Form D)
    Form D · items 06b · filed Aug 26, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 12, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 12, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 31, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 31, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Jan 7, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 9, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Oct 8, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.03, 5.02, 5.03, 9.01 · filed Oct 2, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 2, 2025 · filing
  • Regulation A offering: Regulation A offering statement
    Form 1-A · filed Jan 31, 2025 · filing
  • Crowdfunding (Form C)
    Form C · filed Oct 22, 2024 · filing
  • Crowdfunding (Form C)
    Form C · filed May 22, 2024 · filing